Analysts expect Pharvaris N.V. to report revenue of 0.00 for Q2 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q1 26, came in at 0.00.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.81 M | 4.66 M | 6.57 M | 6.29 M | 54.69 M | |||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.51 M | 4.21 M | 5.69 M | 5.58 M | 50.10 M | |||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.66 M | 4.43 M | 6.13 M | 5.94 M | 52.39 M |
Analysts expect Pharvaris N.V. to report earnings per share of -0.78 for Q2 26, against a range of -0.82 to -0.74. The most recent reported quarter, Q1 26, came in at -0.68, a 12.8% beat against the -0.78 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.59 | -0.86 | -0.66 | -0.92 | -0.98 | -0.70 | -0.85 | -0.68 | - | - | - | - |
| High Estimate | -0.53 | -0.64 | -0.74 | -0.74 | -0.83 | -0.75 | -0.65 | -0.71 | -0.74 | -0.70 | -0.85 | -0.80 |
| Low Estimate | -0.59 | -0.74 | -0.86 | -0.86 | -0.93 | -0.87 | -0.71 | -0.85 | -0.82 | -0.76 | -0.91 | -0.92 |
| Consensus Estimate | -0.56 | -0.69 | -0.80 | -0.80 | -0.88 | -0.81 | -0.68 | -0.78 | -0.78 | -0.73 | -0.88 | -0.86 |